Said differently, to identify the payment amount benchmark period for the purpose of calculating the benchmark period manufacturer price for a Part D rebatable drug first approved or licensed on or before October 1, 2021, CMS would first look to the period from January 1, 2021, to September 30, 2021 and if no AMP was reported under the MDRP for that 3-quarter period, CMS would then identify the payment amount benchmark period as the first calendar year no earlier than calendar year 2021 in which such drug has at least 1 quarter of AMP reported
Each protocol is tailored to your unique health goals using current clinical evidence and best practices
Always work with pharmacies that have top accreditations
Choose TB-500 if: You want overall tissue regeneration and improved blood flow You are recovering from muscle injuries, surgery, or cardiovascular tissue damage Choose BPC-157 if: You need targeted tendon or ligament healing You have joint pain, stiffness, or gut issues Youre recovering from orthopedic surgery or tendonitis Consider Both if: You want a comprehensive healing approach that addresses both systemic tissue repair and targeted connective tissue recovery